2015
DOI: 10.1016/j.reprotox.2014.11.011
|View full text |Cite
|
Sign up to set email alerts
|

A high throughput screening system for predicting chemically-induced reproductive organ deformities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 25 publications
(26 citation statements)
references
References 56 publications
0
22
0
Order By: Relevance
“…This is different from the ToxCast test panel that includes a wider range of mechanisms with multiple tests per mechanistic endpoint [21]. Results suggest that it may not be needed to include a range of assays for each endpoint to make good predictions of in vivo activity of chemicals, as was shown for the estrogen receptor reporter gene assays [20]. This is consistent with the earlier notion that transactivation of ERs in one assay, ER subtype or species can be extrapolated to other species or subtypes of ERs for the purpose of chemical screening in the current practice of risk assessment relying on relatively uninformative animal data [29].…”
Section: Establish a High Throughput Mechanistic Pathway Screen For Rmentioning
confidence: 95%
See 4 more Smart Citations
“…This is different from the ToxCast test panel that includes a wider range of mechanisms with multiple tests per mechanistic endpoint [21]. Results suggest that it may not be needed to include a range of assays for each endpoint to make good predictions of in vivo activity of chemicals, as was shown for the estrogen receptor reporter gene assays [20]. This is consistent with the earlier notion that transactivation of ERs in one assay, ER subtype or species can be extrapolated to other species or subtypes of ERs for the purpose of chemical screening in the current practice of risk assessment relying on relatively uninformative animal data [29].…”
Section: Establish a High Throughput Mechanistic Pathway Screen For Rmentioning
confidence: 95%
“…The first approach in simplification of the testing battery was directed towards inclusion of integrative medium throughput assays that can be run in a routine laboratory environment, avoiding assays with differentiated (primary) tissues as present in the ReProTect battery. This can then be combined with more high throughput assays (see next section) thereby enhancing throughput and further simplifying test procedures [20]. The next step would be to validate this battery and select the most promising assays needed to give proper predictions of reproductive toxicity of chemicals.…”
Section: Establish Sensitive Parameters and A Medium Throughput In VImentioning
confidence: 99%
See 3 more Smart Citations